Early Co-Administration of Crystalloid Fluid and Norepinephrine for Preventing Acute Kidney Injury in Septic Shock

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Septic Shock; Acute Kidney Injury Interventions: Drug: Norepinephrine; Other: Crystalloid Fluid Resuscitation Sponsors: Universitas Sumatera Utara Not yet recruiting Conditions: Septic Shock; Acute Kidney Injury Interventions: Drug: Norepinephrine;...

Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Healthy Adult Participants Interventions: Behavioral: Continuous moderate intensity physical activity; Behavioral: Light-intensity physical activity breaks; Behavioral: High-intensity physical activity breaks Sponsors: Hasselt University Not yet...

Sex Hormones Impact on Cannabis Response

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Cannabis Interventions: Drug: Cannabis; Drug: Knaster Hemp Sponsors: Maastricht University Recruiting Conditions: Cannabis Interventions: Drug: Cannabis; Drug: Knaster Hemp Sponsors: Maastricht University...

Advanced MRI in IVH

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Intraventricular Hemorrhage Neonatal; Post-hemorrhagic Hydrocephalus Interventions: Diagnostic Test: Advanced MRI Sponsors: Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children’s NHS Foundation Trust Not yet...

A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Pharmakokinetic; Open Label; Phase 1 Interventions: Drug: TNX-102 SL Tablet Sponsors: Tonix Pharmaceuticals, Inc.; Syneos Health Active, not recruiting Conditions: Pharmakokinetic; Open Label; Phase 1 Interventions: Drug: TNX-102 SL Tablet Sponsors:...